Document Detail

miRNAs as therapeutic targets in ischemic heart disease.
MedLine Citation:
PMID:  20560049     Owner:  NLM     Status:  MEDLINE    
Ischemic heart disease is a form of congestive heart failure that is caused by insufficient blood supply to the heart, resulting in a loss of viable tissue. In response to the injury, the non-ischemic myocardium displays signs of secondary remodeling, like interstitial fibrosis and hypertrophy of cardiac myocytes. This remodeling process further deteriorates pump function and increases susceptibility to arrhythmias. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression in a sequence-dependent manner. Recently, several groups identified miRNAs as crucial gene regulators in response to myocardial infarction (MI) and during post-MI remodeling. In this review, we discuss how modulation of these miRNAs represents a promising new therapeutic strategy to improve the clinical outcome in ischemic heart disease.
Robert J A Frost; Eva van Rooij
Related Documents :
16332309 - Clinical modifiers for heart failure following myocardial infarction.
23735369 - A rare case of percutaneous coronary intervention in achondroplasia.
22172429 - Rationale and design of the coronary artery bypass grafting surgery off or on pump reva...
9791739 - Heart rate variability in patients with the first and recurrent myocardial infarction.
6476949 - Operative intervention for postinfarction angina.
22368379 - Ventricular tachycardia precipitated by short-long-short sequence in a patient with imp...
8890759 - The cause-effect relationship of sympathovagal activity and the outcome of percutaneous...
2953429 - Thromboembolic complications of percutaneous transluminal coronary angioplasty for myoc...
7562889 - Relation between age, left ventricular mass and ventricular arrhythmias in patients wit...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-03-30
Journal Detail:
Title:  Journal of cardiovascular translational research     Volume:  3     ISSN:  1937-5395     ISO Abbreviation:  J Cardiovasc Transl Res     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-18     Completed Date:  2010-10-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101468585     Medline TA:  J Cardiovasc Transl Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  280-9     Citation Subset:  IM    
Department of Molecular Biology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-9148, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Gene Expression Regulation
Gene Therapy*
MicroRNAs / metabolism*
Myocardial Ischemia / genetics,  pathology,  physiopathology,  therapy*
Myocardium / metabolism*,  pathology
Treatment Outcome
Ventricular Remodeling / genetics
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  MicroRNAs and Ultraconserved Genes as Diagnostic Markers and Therapeutic Targets in Cancer and Cardi...
Next Document:  Human DNA Methyltransferase 3a does not Associate with MicroRNAs in the Regulation of DNA Methylatio...